The role of postoperative radiotherapy after resection of a single brain metastasis: Combined analysis of 643 patients

Strahlentherapie und Onkologie

Volumn 183, Issue 10, 2007, Pages 576-580

  Nieder, Carsten ^a   Astner, Sabrina T ^b   Grosu, Anca Ligia ^c   Andratschke, Nicolaus H ^b   Molls, Michael ^b  

^a Radiation Oncology Unit   (Norway)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Brain metastases; Cerebral metastases; Neurosurgery; Radiotherapy; Resection

Indexed keywords

ARTICLE; BRAIN DYSFUNCTION; BRAIN METASTASIS; BRAIN RADIATION; CANCER SURGERY; CONTROLLED STUDY; DOSE RESPONSE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; QUALITY OF LIFE; RADIATION DOSE; RISK FACTOR;

BRACHYTHERAPY; BRAIN NEOPLASMS; CRANIAL IRRADIATION; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM SEEDING; PROSPECTIVE STUDIES; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; TIME FACTORS; TREATMENT FAILURE;

EID: 34748867167     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-007-1756-4     Document Type: Article

References (35)

1. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases. A randomized controlled trial. JAMA 2006;295:2483-91.
2. Baumert BG, Rutten I, Dehing-Oberije C, et al. A pathology-based substrate for target volume definition in radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys 2006;66:187-94.
3. Buchsbaum JC, Suh JH, Lee SY, et al. Survival by Radiation Therapy Oncology Group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma. Cancer 2002;94:2265-72.
4. Coucke PA, Zouhair A, Ozsahin M, et al. Focalized external radiotherapy for resected solitary brain metastasis: does the dogma stand? Radiother Oncol 1998;47:99-101.
5. Dosoretz DE, Blitzer PH, Russell AH, et al. Management of solitary metastasis to the brain: the role of elective brain irradiation following complete surgical resection. Int J Radiat Oncol Biol Phys 1980;6:1727-30.
6. Gagel B, Piroth M, Pinkawa M, et al. Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer. A phase I study. Strahlenther Onkol 2006;182:263-9.
7. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-51.
8. Grosu AL, Molls M, Zimmermann FB, et al. High-precision radiation therapy with integrated biological imaging and tumor monitoring. Evolution of the Munich concept and future research options. Strahlenther Onkol 2006;182:361-8.
9. Heflin LH, Meyerowitz BE, Hall P, et al. Cancer as a risk factor for long-term cognitive deficits and dementia. J Natl Cancer Inst 2005;97:854-6.
10. Iwadate Y, Namba H, Yamaura A. Whole-brain radiation therapy is not beneficial as an adjuvant therapy for brain metastases compared with localized irradiation. Anticancer Res 2002;22:325-30.
11. Klein M, Heimans JJ, Aaronson NK, et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 2002;360:1361-8.
12. Kocher M, Eich HT, Semrau R, et al. Phase I/II trial of simultaneous whole-brain irradiation and dose-escalating topotecan for brain metastases. Strahlenther Onkol 2005;181:20-5.
13. Komaki R, Meyers CA, Shin DM, et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 1995;33:179-82.
14. Maiuri F, Iaconetta G, Gangemi M, et al. Brain metastases: a survey of the surgical treatment of 240 patients. Cancer J 1998;11:76-81.
15. Meyers CA, Smith JA, Bezjak A, et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 2004;22:157-65.
16. Mintz AH, Kestle J, Rathbone MP, et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996;78:1470-6.
17. Muacevic A, Kreth FW, Horstmann GA, et al. Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter. J Neurosurg 1999;91:35-43.
18. Nieder C, Leicht A, Motaref B, et al. Late radiation toxicity after whole brain radiotherapy: the influence of antiepileptic drugs. Am J Clin Oncol 1999;22:573-9.
19. Nieder C, Schwerdtfeger K, Steudel WI, et al. Patterns of relapse and late toxicity after resection and whole-brain radiotherapy for solitary brain metastases. Strahlenther Onkol 1998;174:275-8.
20. Noordijk EM, Vecht CJ, Haaxma-Reiche H, et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity. Int J Radiat Oncol Biol Phys 1994;29:711-7.
21. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998;280:1485-9.
22. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500.
23. Paulsen F, Scheiderbauer J, Eschmann SM, et al. First experiences of radiation treatment planning with PET/CT. Strahlenther Onkol 2006;182:369-75.
24. Rades D, Raabe A, Bajrovic A, et al. Treatment of solitary brain metastasis. Strahlenther Onkol 2004;180:144-7.
25. Rogers LR, Rock JP, Sills AK, et al. Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases. J Neurosurg 2006;105:375-84.
26. Rugo HS, Ahles T. The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research. Semin Oncol 2003;30:749-62.
27. Sause WT, Crowley JJ, Morantz R, et al. Solitary brain metastasis: results of an RTOG/SWOG protocol evaluation surgery plus RT versus RT alone. Am J Clin Oncol 1990;13:427-32.
28. Schackert G, Steinmetz A, Meier U, et al. Surgical management of single and multiple brain metastases: results of a retrospective study. Onkologie 2001;24:246-55.
29. Schöggl A, Kitz K, Reddy M, et al. Defining the role of stereotactic radiosurgery versus microsurgery in the treatment of single brain metastases. Acta Neurochir (Wien) 2000;142:621-6.
30. Smalley SR, Schray MF, Laws ER, et al. Adjuvant radiation therapy after surgical resection of solitary brain metastasis: association with pattern of failure and survival. Int J Radiat Oncol Biol Phys 1987;13:1611-6.
31. Stark AM, Tscheslog H, Buhl R, et al. Surgical treatment for brain metastases: prognostic factors and survival in 177 patients. Neurosurg Rev 2005;28:115-9.
32. Stranzl H, Ofner P, Peintinger F. Postoperative irradiation in breast cancer patients with one to three positive axillary lymph nodes. Is there an impact of axillary extranodal tumor extension on locoregional and distant control? Strahlenther Onkol 2006;182:583-8.
33. Weil RJ, Lonser RR. Selective excision of metastatic brain tumors originating in the motor cortex with preservation of function. J Clin Oncol 2005;23:1209-17.
34. Wronski M, Arbit E. Resection of brain metastases from colorectal carcinoma in 73 patients. Cancer 1999;85:1677-85.
35. Wronski M, Arbit E. Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients. J Neurosurg 2000;93:9-18.